S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q2 2021

Baker Bros Advisors

Periodo: Q2 2021 Β· Depositato: 2021-08-16
Vedi su SEC EDGAR β†—
AUM
$22.77B
Valore totale del portafoglio
Posizioni
120
Titoli dichiarati
Prima Posizione
SGEN
32.8% $7.47B
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-08-16) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SGENSeagen Inc.$7.47B32.79%β€”β€”
32.8%
ONCBeiGene, Ltd.$4.00B17.59%$343.19$297.65-13.3%
17.6%
INCYIncyte Corporation$2.69B11.83%$84.13$116.86+38.9%
11.8%
KODKodiak Sciences Inc.$1.31B5.77%$93.00$38.54-58.6%
5.8%
ACADACADIA Pharmaceuticals Inc.$1.02B4.49%$24.39$25.97+6.5%
4.5%
BMRNBioMarin Pharmaceutical Inc.$633.3M2.78%$83.44$58.99-29.3%
2.8%
ASNDAscendis Pharma A/S$465.7M2.05%$131.55$274.50+108.7%
2.0%
NVTAQInvitae Corporation$345.7M1.52%β€”β€”
1.5%
ARGXargenx SE$337.1M1.48%$301.07$939.68+212.1%
1.5%
PRLDPrelude Therapeutics Incorporated$289.9M1.27%$28.63$4.91-82.8%
1.3%
IGMSIGM Biosciences, Inc.$262.6M1.15%β€”β€”
1.1%
ABCLAbCellera Biologics Inc.$229.9M1.01%$22.00$8.11-63.1%
1.0%
MRTXMirati Therapeutics, Inc.$227.7M1.00%β€”β€”
1.0%
BCRXBioCryst Pharmaceuticals, Inc.$201.0M0.88%$15.81$9.84-37.8%
0.9%
MDGLMadrigal Pharmaceuticals, Inc.$146.0M0.64%$97.41$528.10+442.1%
0.6%
APLSApellis Pharmaceuticals, Inc.$143.6M0.63%$63.20β€”
0.6%
HRTXHeron Therapeutics, Inc.$126.2M0.55%$15.52$0.44-97.2%
0.6%
AMRNXXXXAmarin Corporation plc$115.9M0.51%β€”β€”
0.5%
GBTGlobal Blood Therapeutics, Inc.$112.7M0.49%β€”β€”
0.5%
PACBPacific Biosciences of California, Inc.$112.0M0.49%$34.97$1.68-95.2%
0.5%
IMCRImmunocore Holdings plc$98.4M0.43%$39.05$32.50-16.8%
0.4%
KYMRKymera Therapeutics, Inc.$95.0M0.42%$48.50$113.51+134.0%
0.4%
VSTMXXXXVerastem, Inc.$87.5M0.38%β€”β€”
0.4%
VERVVerve Therapeutics, Inc.$85.3M0.37%β€”β€”
0.4%
TLISTalis Biomedical Corporation$83.5M0.37%β€”β€”
0.4%
CERSCerus Corporation$81.0M0.36%$5.91$3.16-46.5%
0.4%
DBVTDBV Technologies S.A.$79.8M0.35%$10.92$15.82+44.9%
0.3%
RYTMRhythm Pharmaceuticals, Inc.$75.6M0.33%$19.58$114.17+483.1%
0.3%
TILInstil Bio, Inc.$75.2M0.33%$386.40$7.73-98.0%
0.3%
LEGNLegend Biotech Corporation$68.3M0.30%$41.05$29.91-27.1%
0.3%

AttivitΓ  Trimestre su Trimestre

Q2 2021 vs. Q1 2021

Nuove Posizioni (8)

TickerEmittenteNozionale
VERVVerve Therapeutics, Inc.$85.3M
Insmed Incorporated$44.1M
AVTEAerovate Therapeutics, Inc.$32.6M
Apellis Pharmaceuticals, Inc.$27.8M
Tricida, Inc.$27.3M
CYTTCyteir Therapeutics, Inc.$17.4M
CNTACentessa Pharmaceuticals plc$8.9M
BMEABiomea Fusion, Inc.$4.6M

Posizioni Chiuse (8)

TickerEmittenteNozionale
ALXNAlexion Pharmaceuticals, Inc.$610.6M
CCXIChemoCentryx, Inc.$33.6M
XNCRXencor, Inc.$15.9M
SGMOSangamo Therapeutics, Inc.$5.4M
SRPTSarepta Therapeutics, Inc.$4.4M
CNSTConstellation Pharmaceuticals, Inc.$2.7M
IDRAIdera Pharmaceuticals, Inc.$2.7M
AUTLAutolus Therapeutics plc$2.6M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
LEGNLegend Biotech Corporation$65.0M+1339.6%-27.1%
Sarepta Therapeutics, Inc.$26.5M+218.0%
CHMAChiasma, Inc.$4.4M+91.4%
ORTXOrchard Therapeutics plc$-0.1M+62.3%
CRNXCrinetics Pharmaceuticals, Inc.$7.9M+49.3%
KDNYChinook Therapeutics, Inc.$3.6M+44.3%
ASMBAssembly Biosciences, Inc.$1.1M+36.8%
APLSApellis Pharmaceuticals, Inc.$71.8M+35.7%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
SYRSSyros Pharmaceuticals, Inc.$-4.8M-90.5%
PTGXProtagonist Therapeutics, Inc.$-16.8M-68.3%
MREOMereo BioPharma Group plc$-14.8M-63.4%
ALTAltimmune, Inc.$-28.4M-61.1%
PASGPassage Bio, Inc.$-2.6M-50.2%
GMDAQGamida Cell Ltd.$-4.5M-41.1%
NVTAQInvitae Corporation$-256.1M-34.9%
AUPHAurinia Pharmaceuticals Inc.$-3.8M-20.6%
← Torna agli Hedge Fund